U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07037563) titled 'Developing an AI Pharmacy Chatbot for the Population of Hong Kong' on June 17.
Brief Summary: The primary objective of this study is to is to develop a conversational AI service (chatbot) in Hong Kong to assist patients and caregivers with inquires related to Hospital Authority (HA)-prescribed medications, and to evaluate its effectiveness in answering medication-related questions. The main questions it aims to answer are:
1. How satisfied are the patients and caregivers with this pharmacy chatbot?
2. How will the pharmacy chatbot impact eligible patients or caregivers on their (or the patient they are caring for) medication adher...